Vancomycin — Adverse Effects
A patient turns bright red during a vancomycin infusion — is it anaphylaxis or Red Man Syndrome? Your next action depends entirely on knowing the difference.
Core Concept
Vancomycin's major adverse effects are Red Man Syndrome (RMS), nephrotoxicity, and ototoxicity. RMS is a histamine-mediated reaction — not a true allergy — triggered by infusing too fast. It presents as flushing, erythema of the face/neck/upper torso, pruritus, and sometimes hypotension. The intervention is to pause the infusion, notify the provider, and expect orders to restart at a slower rate with diphenhydramine premedication. Standard infusion time is at least 60 minutes per 1 g; faster rates dramatically increase RMS risk. Nephrotoxicity risk increases when vancomycin is combined with other nephrotoxic agents such as aminoglycosides, NSAIDs, or IV contrast. Monitor serum creatinine and BUN at baseline and throughout therapy. Trough levels are drawn 30 minutes before the next dose; the target trough range is typically 15–20 mcg/mL for serious infections, though levels above 20 mcg/mL sharply raise nephrotoxicity risk. Ototoxicity manifests as tinnitus, hearing loss, or vertigo and may be irreversible. Report any auditory complaints immediately. Adequate hydration is essential to protect the kidneys throughout therapy.
Watch Out For
Don't confuse RMS with anaphylaxis — RMS lacks urticaria/wheals, bronchospasm, and angioedema; it's rate-related, not immune-mediated. Students often mix up vancomycin trough timing (30 minutes before the dose) with aminoglycoside peak timing (30–60 minutes after). Ototoxicity from vancomycin can be permanent, unlike many drug-induced GI side effects that resolve after discontinuation.
Clinical Pearl
Red Man = Rate Man. Slow the drip, and the red goes away. True allergy gets worse no matter the rate — that's the distinction that saves you on test day.
Test Your Knowledge
3 quick questions — see how well you understood Vancomycin — Adverse Effects